About the Journal

Journal of Pharmacology and Drug Metabolism is an international, peer-reviewed, open access journal dedicated to publishing high-quality research and scholarly contributions in the fields of pharmacology, drug metabolism, pharmacokinetics, pharmacodynamics, toxicology, and related areas of pharmaceutical and biomedical sciences. The journal provides a global platform for researchers, pharmacologists, clinicians, pharmaceutical scientists, healthcare professionals, and academicians to share innovative discoveries, emerging concepts, and significant advances that contribute to the understanding of drugs and their effects on biological systems.

In an era of rapidly evolving drug discovery technologies, precision therapeutics, and personalized medicine, the generation and dissemination of reliable scientific knowledge are essential for improving drug development and patient care. The Journal of Pharmacology and Drug Metabolism aims to promote excellence in research and facilitate the international exchange of scientific knowledge, bridging fundamental laboratory research with translational and clinical applications.

The journal welcomes original and significant research that advances the understanding of drug actions, mechanisms of pharmacological activity, absorption, distribution, metabolism, and excretion (ADME), drug-drug interactions, pharmacogenomics, therapeutic drug monitoring, and drug safety. Contributions addressing novel therapeutic agents, molecular mechanisms, preclinical and clinical pharmacology, and emerging approaches in drug development are particularly encouraged.

As an international journal, Journal of Pharmacology and Drug Metabolism welcomes high-quality submissions from researchers and institutions worldwide. The journal encourages interdisciplinary collaboration among scientists working across pharmacology, medicinal chemistry, pharmaceutical sciences, toxicology, biotechnology, medicine, and related disciplines. By promoting the exchange of ideas and research findings, the journal seeks to support scientific innovation and contribute to the development of safer and more effective therapeutic strategies.

The journal provides equal opportunities for researchers from all regions to disseminate their scientific work, supporting diversity and inclusivity in global scientific communication. Through broad international participation, the journal aims to contribute to the advancement of pharmacological research and the understanding of drug-related processes that influence human health and disease treatment.

Peer Review Excellence

The journal follows a rigorous double-blind peer review process, ensuring that both authors and reviewers remain anonymous throughout the evaluation process. This approach eliminates bias and guarantees a fair, objective, and transparent review of all submitted manuscripts.

Each submission undergoes a thorough assessment by qualified experts in the relevant field, who evaluate the manuscript based on originality, scientific validity, methodological soundness, and relevance to the journal’s focus. The editorial board carefully considers reviewers’ feedback before making final decisions regarding acceptance, revision, or rejection.

To meet the needs of researchers requiring timely publication, the journal also offers a fast-track review process, enabling rapid evaluation and publication of high-priority manuscripts without compromising the quality of peer review. This feature is particularly beneficial for time-sensitive research findings and emerging scientific developments.

Open Access Policy and Creative Commons Licensing

Journal of Pharmacology and Drug Metabolism operates under a full open access publishing model, ensuring that all articles are freely accessible to readers worldwide without subscription barriers. This approach enhances the dissemination and impact of research, allowing knowledge to reach a broader audience including researchers, clinicians, policymakers, and the general public.

All published articles are distributed under Creative Commons licensing, which permits users to read, download, copy, distribute, and reproduce the content in any medium, provided that appropriate credit is given to the original authors. This policy supports the principles of transparency, accessibility, and knowledge sharing in scientific research.

Open access publishing not only increases the visibility of authors’ work but also contributes to higher citation rates and broader academic recognition.

Digital Identification and Indexing Support

To ensure the long-term accessibility and traceability of published research, the journal assigns a Digital Object Identifier (DOI) to each article through Crossref. This enables accurate citation, easy retrieval, and integration with global research databases.

In addition, all published articles are submitted for indexing in Google Scholar after publication, enhancing discoverability and ensuring that research is accessible to the global academic community. The journal continuously works toward inclusion in additional indexing and abstracting databases to further expand its reach and credibility

Language and Accessibility

The journal publishes all manuscripts in English, the universally accepted language of scientific communication. This ensures clarity, consistency, and accessibility for an international audience.

Authors are encouraged to present their research in a clear and concise manner, enabling readers from diverse academic and professional backgrounds to understand and apply the findings effectively. The journal also supports the use of standardized scientific terminology and formatting to maintain consistency across publications.

Ethical Standards and Integrity

The journal is committed to maintaining the highest standards of publication ethics and academic integrity. All submissions are expected to be original and free from plagiarism, data fabrication, or any form of unethical practice.

Authors are required to disclose any potential conflicts of interest and ensure that their research complies with ethical guidelines, particularly in studies involving human participants or animals. The journal follows internationally recognized ethical standards to safeguard the credibility and reliability of published research.

By enforcing strict ethical policies, the journal ensures trust among authors, reviewers, and readers.

Contribution to Scientific Advancement

The primary objective of the Journal of Pharmacology and Drug Metabolism is to contribute to the advancement of knowledge in pharmacological and drug-related sciences. By publishing high-quality research and encouraging interdisciplinary collaboration, the journal seeks to support progress in understanding drug mechanisms, metabolism, therapeutic efficacy, and safety.

The journal welcomes innovative studies that contribute to drug discovery and development, pharmacological characterization, pharmacokinetic and pharmacodynamic evaluation, drug metabolism, toxicological assessment, therapeutic drug monitoring, and personalized medicine. Research that promotes the translation of scientific discoveries into improved therapeutic approaches and better healthcare outcomes is particularly encouraged.

Through its commitment to scientific quality, open accessibility, ethical publishing, and international collaboration, the Journal of Pharmacology and Drug Metabolism aims to serve as a valuable source of current knowledge for researchers, clinicians, pharmaceutical scientists, and healthcare professionals.

By fostering innovation and ensuring the widespread availability of research findings, the journal contributes to advancing knowledge in pharmacology and drug metabolism, supporting the development of safer and more effective therapeutic approaches and ultimately improving healthcare outcomes and human well-being worldwide.